India, Dec. 11 -- Healthtech startup Inito has raised $29 Mn (INR 261.9 Cr) in a Series B funding round co-led by Bertelsmann India Investments (BII) and existing investor Fireside Ventures.

With this investment, the startup is looking to expand its offerings beyond fertility to build a broader at-home hormone and health diagnostics platform powered by AI-engineered antibodies

"The new capital accelerates Inito's work that allows diagnostic tests to be designed in silico rather than developed through slow, inconsistent, animal-based methods, setting the stage for faster innovation and a wider range of at-home tests that can reach more people worldwide," the healthtech platform said in a statement.

Founded in 2015 by Aayush Rai and Varu...